GLOB.HEALTH CLINICS O.N. (F:L00) — Market Cap & Net Worth
Market Cap & Net Worth: GLOB.HEALTH CLINICS O.N. (L00)
GLOB.HEALTH CLINICS O.N. (F:L00) has a market capitalization of $117.40K (€100.42K) as of September 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #31459 globally and #2806 in its home market, demonstrating a 5740.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GLOB.HEALTH CLINICS O.N.'s stock price €0.03 by its total outstanding shares 9392138 (9.39 Million). Also see GLOB.HEALTH CLINICS O.N. (L00) total assets for a full breakdown of the balance sheet.
GLOB.HEALTH CLINICS O.N. Market Cap History: 2015 to 2026
GLOB.HEALTH CLINICS O.N.'s market capitalization history from 2015 to 2026. Data shows change from $4.39 Million to $320.63K (-44.72% CAGR). Also see L00 cash generation efficiency for how efficiently the company converts equity into cash flow.
GLOB.HEALTH CLINICS O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GLOB.HEALTH CLINICS O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check GLOB.HEALTH CLINICS O.N. (L00) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.11x
GLOB.HEALTH CLINICS O.N.'s market cap is 0.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $334.90K | $146.81K | -$1.37 Million | 2.28x | N/A |
| 2023 | $5.49K | $102.85K | -$1.63 Million | 0.05x | N/A |
| 2024 | $5.49K | $82.96K | -$1.08 Million | 0.07x | N/A |
| 2025 | $5.49K | $47.77K | -$1.27 Million | 0.11x | N/A |
Competitor Companies of L00 by Market Capitalization
Companies near GLOB.HEALTH CLINICS O.N. in the global market cap rankings as of September 18, 2026. Explore L00 net asset momentum to track how rapidly the company is growing its equity base year over year.
Key companies related to GLOB.HEALTH CLINICS O.N. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #519 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #633 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #640 globally with a market cap of $43.16 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.62 Billion USD ( CN¥277.61 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #519 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #633 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #640 | GALDERMA GROUP AG | NYSE:GALDY | $43.16 Billion | $37.02 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.62 Billion | CN¥43.52 |
GLOB.HEALTH CLINICS O.N. Historical Marketcap From 2015 to 2026
Between 2015 and today, GLOB.HEALTH CLINICS O.N.'s market cap moved from $4.39 Million to $ 320.63K, with a yearly change of -44.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €320.63K | +5740.00% |
| 2025 | €5.49K | 0.00% |
| 2024 | €5.49K | 0.00% |
| 2023 | €5.49K | -98.36% |
| 2022 | €334.90K | -91.76% |
| 2021 | €4.06 Million | -85.77% |
| 2020 | €28.55 Million | +306.25% |
| 2019 | €7.03 Million | -96.44% |
| 2018 | €197.65 Million | -87.76% |
| 2017 | €1.61 Billion | +36650.00% |
| 2015 | €4.39 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of GLOB.HEALTH CLINICS O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $117.40K USD |
| MoneyControl | $117.40K USD |
| MarketWatch | $117.40K USD |
| marketcap.company | $117.40K USD |
| Reuters | $117.40K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GLOB.HEALTH CLINICS O.N.
Global Health Clinics Ltd. operates in the cannabis industry. It operates medical clinics, which guide patients through the process of becoming legal users of marijuana. The company was formerly known as Leo Resources Inc. and changed its name to Global Health Clinics Ltd. in August 2018. Global Health Clinics Ltd. was incorporated in 2013 and is headquartered in Vancouver, Canada.